These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 17166884

  • 1. Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer.
    Pylkäs K, Tommiska J, Syrjäkoski K, Kere J, Gatei M, Waddell N, Allinen M, Karppinen SM, Rapakko K, Kääriäinen H, Aittomäki K, Blomqvist C, Mustonen A, Holli K, Khanna KK, Kallioniemi OP, Nevanlinna H, Winqvist R.
    Carcinogenesis; 2007 May; 28(5):1040-5. PubMed ID: 17166884
    [Abstract] [Full Text] [Related]

  • 2. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.
    Dörk T, Bendix R, Bremer M, Rades D, Klöpper K, Nicke M, Skawran B, Hector A, Yamini P, Steinmann D, Weise S, Stuhrmann M, Karstens JH.
    Cancer Res; 2001 Oct 15; 61(20):7608-15. PubMed ID: 11606401
    [Abstract] [Full Text] [Related]

  • 3. The role of ATM in breast cancer development.
    Prokopcova J, Kleibl Z, Banwell CM, Pohlreich P.
    Breast Cancer Res Treat; 2007 Aug 15; 104(2):121-8. PubMed ID: 17061036
    [Abstract] [Full Text] [Related]

  • 4. A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer.
    Bogdanova N, Cybulski C, Bermisheva M, Datsyuk I, Yamini P, Hillemanns P, Antonenkova NN, Khusnutdinova E, Lubinski J, Dörk T.
    Breast Cancer Res Treat; 2009 Nov 15; 118(1):207-11. PubMed ID: 18807267
    [Abstract] [Full Text] [Related]

  • 5. ATM mutations in cancer families.
    Vorechovský I, Luo L, Lindblom A, Negrini M, Webster AD, Croce CM, Hammarström L.
    Cancer Res; 1996 Sep 15; 56(18):4130-3. PubMed ID: 8797579
    [Abstract] [Full Text] [Related]

  • 6. Frequency of the ATM IVS10-6T-->G variant in Australian multiple-case breast cancer families.
    Lindeman GJ, Hiew M, Visvader JE, Leary J, Field M, Gaff CL, Gardner RJ, Trainor K, Cheetham G, Suthers G, Kirk J.
    Breast Cancer Res; 2004 Sep 15; 6(4):R401-7. PubMed ID: 15217508
    [Abstract] [Full Text] [Related]

  • 7. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
    Paglia LL, Laugé A, Weber J, Champ J, Cavaciuti E, Russo A, Viovy JL, Stoppa-Lyonnet D.
    Breast Cancer Res Treat; 2010 Jan 15; 119(2):443-52. PubMed ID: 19404735
    [Abstract] [Full Text] [Related]

  • 8. Contribution of mutations in ATM to breast cancer development in the Czech population.
    Soukupova J, Dundr P, Kleibl Z, Pohlreich P.
    Oncol Rep; 2008 Jun 15; 19(6):1505-10. PubMed ID: 18497957
    [Abstract] [Full Text] [Related]

  • 9. ATM variants and cancer risk in breast cancer patients from Southern Finland.
    Tommiska J, Jansen L, Kilpivaara O, Edvardsen H, Kristensen V, Tamminen A, Aittomäki K, Blomqvist C, Børresen-Dale AL, Nevanlinna H.
    BMC Cancer; 2006 Aug 16; 6():209. PubMed ID: 16914028
    [Abstract] [Full Text] [Related]

  • 10. Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families.
    Cavaciuti E, Laugé A, Janin N, Ossian K, Hall J, Stoppa-Lyonnet D, Andrieu N.
    Genes Chromosomes Cancer; 2005 Jan 16; 42(1):1-9. PubMed ID: 15390180
    [Abstract] [Full Text] [Related]

  • 11. Two ATM variants and breast cancer risk.
    Thompson D, Antoniou AC, Jenkins M, Marsh A, Chen X, Wayne T, Tesoriero A, Milne R, Spurdle A, Thorstenson Y, Southey M, Giles GG, Khanna KK, Sambrook J, Oefner P, Goldgar D, Hopper JL, Easton D, Chenevix-Trench G, KConFab Investigators.
    Hum Mutat; 2005 Jun 16; 25(6):594-5. PubMed ID: 15880680
    [Abstract] [Full Text] [Related]

  • 12. Contributions of ATM mutations to familial breast and ovarian cancer.
    Thorstenson YR, Roxas A, Kroiss R, Jenkins MA, Yu KM, Bachrich T, Muhr D, Wayne TL, Chu G, Davis RW, Wagner TM, Oefner PJ.
    Cancer Res; 2003 Jun 15; 63(12):3325-33. PubMed ID: 12810666
    [Abstract] [Full Text] [Related]

  • 13. Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry.
    Graña B, Fachal L, Darder E, Balmaña J, Ramón Y Cajal T, Blanco I, Torres A, Lázaro C, Diez O, Alonso C, Santamariña M, Velasco A, Teulé A, Lasa A, Blanco A, Izquierdo A, Borràs J, Gutiérrez-Enríquez S, Vega A, Brunet J.
    Breast Cancer Res Treat; 2011 Jul 15; 128(2):573-9. PubMed ID: 21445571
    [Abstract] [Full Text] [Related]

  • 14. IVS10-6T>G, an ancient ATM germline mutation linked with breast cancer.
    Broeks A, Urbanus JH, de Knijff P, Devilee P, Nicke M, Klöpper K, Dörk T, Floore AN, van't Veer LJ.
    Hum Mutat; 2003 May 15; 21(5):521-8. PubMed ID: 12673794
    [Abstract] [Full Text] [Related]

  • 15. Histopathological features of breast cancer in carriers of ATM gene variants.
    Balleine RL, Murali R, Bilous AM, Farshid G, Waring P, Provan P, Byth K, Thorne H, kConFab Investigators, Kirk JA.
    Histopathology; 2006 Nov 15; 49(5):523-32. PubMed ID: 17064299
    [Abstract] [Full Text] [Related]

  • 16. Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.
    Spring K, Ahangari F, Scott SP, Waring P, Purdie DM, Chen PC, Hourigan K, Ramsay J, McKinnon PJ, Swift M, Lavin MF.
    Nat Genet; 2002 Sep 15; 32(1):185-90. PubMed ID: 12195425
    [Abstract] [Full Text] [Related]

  • 17. ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.
    Brunet J, Gutiérrez-Enríquez S, Torres A, Bérez V, Sanjosé S, Galceran J, Izquierdo A, Menéndez JA, Gumà J, Borràs J.
    Clin Genet; 2008 May 15; 73(5):465-73. PubMed ID: 18384426
    [Abstract] [Full Text] [Related]

  • 18. Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.
    Micol R, Ben Slama L, Suarez F, Le Mignot L, Beauté J, Mahlaoui N, Dubois d'Enghien C, Laugé A, Hall J, Couturier J, Vallée L, Delobel B, Rivier F, Nguyen K, Billette de Villemeur T, Stephan JL, Bordigoni P, Bertrand Y, Aladjidi N, Pedespan JM, Thomas C, Pellier I, Koenig M, Hermine O, Picard C, Moshous D, Neven B, Lanternier F, Blanche S, Tardieu M, Debré M, Fischer A, Stoppa-Lyonnet D, CEREDIH Network Investigators.
    J Allergy Clin Immunol; 2011 Aug 15; 128(2):382-9.e1. PubMed ID: 21665257
    [Abstract] [Full Text] [Related]

  • 19. ATM and breast cancer susceptibility.
    Ahmed M, Rahman N.
    Oncogene; 2006 Sep 25; 25(43):5906-11. PubMed ID: 16998505
    [Abstract] [Full Text] [Related]

  • 20. The role of ataxia-telangiectasia heterozygotes in familial breast cancer.
    Chen J, Birkholtz GG, Lindblom P, Rubio C, Lindblom A.
    Cancer Res; 1998 Apr 01; 58(7):1376-9. PubMed ID: 9537233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.